JPWO2024096066A1 - - Google Patents
Info
- Publication number
- JPWO2024096066A1 JPWO2024096066A1 JP2024554562A JP2024554562A JPWO2024096066A1 JP WO2024096066 A1 JPWO2024096066 A1 JP WO2024096066A1 JP 2024554562 A JP2024554562 A JP 2024554562A JP 2024554562 A JP2024554562 A JP 2024554562A JP WO2024096066 A1 JPWO2024096066 A1 JP WO2024096066A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022177714 | 2022-11-04 | ||
| PCT/JP2023/039446 WO2024096066A1 (ja) | 2022-11-04 | 2023-11-01 | 中枢神経系損傷疾患を処置または予防するための環状ペプチド誘導体組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2024096066A1 true JPWO2024096066A1 (https=) | 2024-05-10 |
Family
ID=90930657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024554562A Pending JPWO2024096066A1 (https=) | 2022-11-04 | 2023-11-01 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4613282A1 (https=) |
| JP (1) | JPWO2024096066A1 (https=) |
| KR (1) | KR20250111317A (https=) |
| CN (1) | CN120152726A (https=) |
| IL (1) | IL320606A (https=) |
| TW (1) | TW202525320A (https=) |
| WO (1) | WO2024096066A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202547546A (zh) * | 2024-02-07 | 2025-12-16 | 日商第一工業製藥股份有限公司 | 用以改善腦功能之環狀肽衍生物組成物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4172896A (en) | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
| GB9217295D0 (en) | 1992-08-14 | 1992-09-30 | Wellcome Found | Controlled released tablets |
| US5541231A (en) | 1993-07-30 | 1996-07-30 | Glaxo Wellcome Inc. | Stabilized Pharmaceutical |
| GB9315856D0 (en) | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
| US5358970A (en) | 1993-08-12 | 1994-10-25 | Burroughs Wellcome Co. | Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
| DE69839355T2 (de) | 1997-07-29 | 2009-06-04 | Alcon Laboratories, Inc., Fort Worth | Ophthalmische Zusammensetzungen enthaltend Galaktomannanpolymere und Borat |
| AU2483599A (en) | 1998-01-29 | 1999-08-16 | Sepracor, Inc. | Pharmaceutical uses of optically pure (-)-bupropion |
| US8889112B2 (en) | 1999-09-16 | 2014-11-18 | Ocularis Pharma, Llc | Ophthalmic formulations including selective alpha 1 antagonists |
| US6933289B2 (en) | 2003-07-01 | 2005-08-23 | Allergan, Inc. | Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
| EP1654002B2 (en) | 2003-08-07 | 2014-01-29 | Allergan, Inc. | Compositions for delivery of therapeutics into the eyes |
| US20050059744A1 (en) | 2003-09-12 | 2005-03-17 | Allergan, Inc. | Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| WO2016047638A1 (ja) * | 2014-09-24 | 2016-03-31 | 国立大学法人岩手大学 | 環状ペプチド誘導体とその製造方法および組成物 |
| JP7486328B2 (ja) * | 2020-03-05 | 2024-05-17 | 株式会社バイオコクーン研究所 | 神経突起伸長促進剤、神経細胞の樹状突起発現促進剤、及び神経栄養因子様作用物質 |
| JP7695662B2 (ja) * | 2020-11-02 | 2025-06-19 | 公立大学法人大阪 | 環状ペプチド誘導体の製造方法及び環状ペプチド化合物の製造方法 |
-
2023
- 2023-11-01 EP EP23885820.3A patent/EP4613282A1/en active Pending
- 2023-11-01 WO PCT/JP2023/039446 patent/WO2024096066A1/ja not_active Ceased
- 2023-11-01 IL IL320606A patent/IL320606A/en unknown
- 2023-11-01 TW TW112142064A patent/TW202525320A/zh unknown
- 2023-11-01 CN CN202380076631.9A patent/CN120152726A/zh active Pending
- 2023-11-01 JP JP2024554562A patent/JPWO2024096066A1/ja active Pending
- 2023-11-01 KR KR1020257017381A patent/KR20250111317A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW202525320A (zh) | 2025-07-01 |
| WO2024096066A1 (ja) | 2024-05-10 |
| KR20250111317A (ko) | 2025-07-22 |
| EP4613282A1 (en) | 2025-09-10 |
| IL320606A (en) | 2025-07-01 |
| CN120152726A (zh) | 2025-06-13 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20260306 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20260306 |